Summary
- Ophthalmologists often have to choose retinal treatments based on cost constraints, not necessarily what is best for the patient’s long-term health.
- The societal and economic impacts of retinal treatments reveal hidden costs that challenge current cost-effectiveness models.
- Studies show that more frequent, expensive treatments are not always more effective than convenient, cheaper options.
- Caretaker costs, missed work, and patient burden can add to the true costs of treatment for patients with poor vision.
- New studies suggest that treating geographic atrophy with longer-acting and more costly drugs could be cost-effective in the long run.
Ophthalmologists at the American Society of Retina Specialists (ASRS) Annual Meeting discussed the challenges of choosing retinal treatments based on financial constraints rather than what might be best for the patient in the long run. Some treatments may be more expensive and require more frequent visits, which can impact the patient’s overall well-being.
Studies have shown that the societal and economic impacts of retinal treatments go beyond direct medical costs, with hidden costs such as missed work due to appointments and the need for caretakers adding to the overall burden. This broader perspective reveals that some treatments, although slightly more effective, may not be the most cost-effective option in the long term.
New metrics, such as “cost-per-area of GA spared,” are being used to analyze the cost-benefit ratio of treatments for conditions like Geographic Atrophy. Research has shown that reducing the frequency of treatment can lead to substantial cost savings without compromising effectiveness, offering physicians more data points to consider in their decision-making process.
Experts emphasize that while cost-effectiveness is an important factor to consider, treatment decisions should not be based solely on cost. Physicians must take into account each patient’s specific clinical context when deciding on the most suitable treatment option. Overall, the goal is to provide the best care for patients while also considering the economic implications of treatment choices.
Source link
Ophthalmology